Koers Biotricity, Inc. Other OTC
Aandelen
BTCY
US09074H1041
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 12 mln. 11,15 mln. | Omzet 2025 * | 14,3 mln. 13,29 mln. | Marktkapitalisatie | 11,84 mln. 11 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,99 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,83 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,74% |
Recentste transcriptie over Biotricity, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Waqaas Al-Siddiq
CEO | Chief Executive Officer | 39 | 29-08-12 |
John Ayanoglou
DFI | Director of Finance/CFO | 57 | 27-10-17 |
Spencer LaDow
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald McClurg
BRD | Director/Board Member | 65 | 04-05-22 |
Chet White
BRD | Director/Board Member | 59 | 11-08-22 |
David Rosa
BRD | Director/Board Member | 59 | 03-05-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,07% | 3,2 mld. | |
-5,53% | 170 mln. | |
-14,17% | 84,67 mln. | |
+31,88% | 61,22 mln. |